Visit our foundation to give a gift.
 View Locations Near Me
Main Campus – Hartford
Connecticut Children’s – Waterbury
Urgent Care – Farmington
Specialty Care Center – Danbury
Connecticut Children’s Surgery Center at FarmingtonÂ
Specialty Care Center – Westport
Search All LocationsÂ
Find a doctorÂ
Contact Us Â
Search SpecialtiesÂ
Find A DoctorÂ
Appointments
Locations
Amenities and Services
Who’s Who on Care Team
Getting Ready for Surgery
What to Expect—Picture Stories
Disney Initiative
Pay a Bill
Understanding the Different Fees
Pricing Transparency and Estimates
Child Life
Raytheon Technologies Family Resource Center
Family Advisory Council
Transition Programs
Advocacy
Legal Advocacy: Benefits, Education, Housing
Electronic Health Records
MyChart
Share Your Story
Pay a BillÂ
Login to MyChartÂ
Specialty Referrals
Clinical Support Services Referrals
Inpatient Referrals
ED/Transport Referrals
About the Network
Join the Network
Graduate Medical Education
Continuing Medical Education
MOC/Practice Quality Improvement
Educating Practices in the Community (EPIC)
For Nurses
Learning & Performance
Research
Resources
CLASP Co-Management
Meet our Physician Relations Team
Request Medical Records
Join our Referring Provider Advisory Board
View our Physician Callback Standards
Read & Subscribe to Medical NewsÂ
Register for Email Updates
Update Your Practice Information
Refer a Patient Â
Contact OneCall Â
Director, Center for Cancer and Blood Disorders Martin J. Gavin Chair of Hematology and Oncology
Education: BA, Rice University, 1977 PhD, Harvard University, 1982 MD, Harvard University, 1994
Residency: Baylor College of Medicine, 1993-1996
Fellowship: Cancer Genetics, Dana-Farber Cancer Center, 1982-1984 Pediatric Hematology & Oncology, Baylor College of Medicine, 1996-1998
Professor of Pediatrics, University of Connecticut School of Medicine and Jackson Laboratory for Genomic Medicine
Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer W, Triche T, Wong KK, Lau CC. (2005) Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res, 65:8142-50.
Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, Hallani SE, Idbaih A, Zelenika D, Anderson U, Henriksson R, Bergenheim AT, Feychting M, Lönn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau CC, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nature Genet, 41:899-904.
Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R; Gliogene Consortium, Melin BS, Bondy ML. (2011) Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res, 71:7568-75. 2011.
Wang L, Yamaguchi S, Burstein MD, Terashima K, Chang K, Ng HK, Nakamura H, He Z, Doddapaneni H, Lewis L, Wang M, Suzuki T, Nishikawa R, Natsume A, Terasaka S, Dauser R, Whitehead W, Adekunle A, Sun J, Qiao Y, Marth G, Muzny DM, Gibbs RA, Leal SM, Wheeler DA & Lau CC (2014). Novel somatic and germline mutations in intracranial germ cell tumors. Nature, 511(7508):241-5.
Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pounds S, Cao X, Ries RE, Wang Z, Chen X, Dong L, Diskin SJ, Smith M, Guidry Auvil JM, Meltzer PS, Lau CC, Perlman EJ, Maris JM, Meshinchi S, Hunger SP, Gerhard DS, Zhang J. Mutational Landscape of the Genomes and Transcriptomes of 1,699 Pediatric Cancers, Nature 2018;555(7696):371-376. doi: 10.1038/nature25795.
Huang L, Garrett Injac S, Cui K, Braun F, Lin Q, Du Y, Zhang H, Kogiso M, Lindsay H, Zhao S, Baxter P, Adekunle A, Man TK, Zhao H, Li XN, Lau CC, Wong STC. Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma. Sci Transl Med. 2018 Oct 24; 10(464): eaat0150. doi: 10.1126/scitranslmed.aat0150. PubMed PMID: 30355798
Amin SB, Anderson KJ, Boudreau CE, Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS, Kassab C, Ling X, Kim H, Barter M, Lau CC, Ngan CY, Chapman M, Koehler JW, Long JP, Miller AD, Miller CR, Porter BF, Rissi DR, Mazcko C, LeBlanc AK, Dickinson PJ, Packer RA, Taylor AR, Rossmeisl JH Jr, Woolard KD, Heimberger AB, Levine JM, Verhaak RGW. Comparative Molecular Life History of Spontaneous Canine and Human Gliomas. Cancer Cell. 2020 Feb 10;37(2):243-257.e7. doi: 1016/j.ccell.2020.01.004. PubMed PMID: 32049048; PubMed Central PMCID: PMC7132629.
ADVANCING PEDIATRIC BRAIN TUMOR CAREÂ
Ching C. Lau, M.D., Ph.D., since 2016 has served as JAX Professor, Division Head in UConn’s Department of Pediatrics’ Division of Pediatric Hematology/Oncology, and Martin J. Gavin Endowed Chair of Hematology-Oncology at Connecticut Children’s. He’s accelerating the pace and success rate of clinical trials in pediatric cancer patients using new genomic technologies to better understand pediatric brain and bone cancers and rapidly develop new therapeutic treatments for patients via translational research, especially difficult to treat brain tumors.
By combining in silico drug screening and mouse model findings with genomic medicine to choose the best therapy for each patient, Lau hopes to improve the speed and outcome of clinical trials and reduce cancer care side effects for children. His latest research is gaining insight on the underlying genomics of common and difficult to treat brain tumor to target them genetically with novel therapeutics. Plus, he’s working to test and reposition current heart drugs to help expand the fight against complicated brain tumors. More recently he is leading an international team of investigators in industry and academia to develop a cloud-based platform to facilitate data sharing and integration through global collaboration.